Skip to main content

Table 2 Clinical implications of molecular imaging in Alzheimer's disease

From: Molecular imaging in Alzheimer's disease: new perspectives on biomarkers for early diagnosis and drug development

To increase the understanding of pathophysiological mechanisms
To increase the understanding of time course of disease progression
To understand the differences in time course between pathology and functional changes
To develop diagnostic markers that can predict rate of progression
To enable selection of Alzheimer's disease patients to certain therapy
To measure brain changes after short-term and long-term therapeutic intervention that correlate with clinical symptoms